טוען...
Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome
Programmed cell death or apoptosis is a prominent feature of low-risk myelodysplastic syndromes (MDS), although the underlying mechanism remains controversial. High-risk MDS have less apoptosis associated with increased expression of the prosurvival BCL2-related proteins. To address the mechanism an...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3448259/ https://ncbi.nlm.nih.gov/pubmed/22855610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-05-430736 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|